FDA announces meetings on ag biotech educational outreach

Meetings planned for Charlotte and San Francisco in November to allow public to share information on biotechnology outreach initiative.

When Congress passed the biotech labeling law in 2016, it also appropriated $3 million to fund the Agricultural Biotechnology Education and Outreach Initiative, which calls upon the Food and Drug Administration to work with the U.S. Department of Agriculture to provide education and outreach to the public on agricultural biotechnology and food and animal feed ingredients derived from biotechnology.

FDA announced two public meetings are scheduled for Charlotte, N.C., and San Francisco, Calif., to provide the public with an opportunity to share information, experiences, and suggestions to help inform the development of this education and outreach initiative.

The initial phase of this initiative is to inform the public of FDA’s work and obtain input from all stakeholders on this issue. 

The Charlotte meeting is planned for Nov. 7 from 8 a.m. to 1 p.m. EST at the Omni Charlottee Hotel. The San Francisco meeting is scheduled for Nov. 14 from 8 a.m. to 1 p.m. PST at the San Francisco Marriott Marquis.

The goal of this initiative is to provide consumer outreach and education through publication and distribution of science-based educational information on the environmental, nutritional, food safety, economic, and humanitarian impacts of agricultural biotechnology. The FDA is currently working on this initiative in consultation with USDA and other federal agencies.

Webcast will be available for both meetings for those who cannot attend in person.

For questions about registering for the meetings or to register via email, mail or fax, contact Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877, 240-449-8427, Fax: 240-641-9042, e-mail: [email protected]

The FDA is accepting public comments on questions listed in the Federal Register Notice. Comments may be submitted beginning on October 13, 2017. Comments will be accepted until November 17, 2017.

To submit comments to the docket electronically, visit www.regulations.gov and type FDA-2017-N-5991 in the search box.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.